Downregulation of Hsp70 inhibits apoptosis induced by sialic acid-binding lectin (leczyme)
- Authors:
- Published online on: October 24, 2013 https://doi.org/10.3892/or.2013.2814
- Pages: 13-18
-
Copyright: © Tatsuta et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
Abstract
Introduction
In response to various types of stress, cells activate a highly conserved heat shock response in which a set of heat shock proteins (Hsps) are induced. These proteins play important roles in cellular repair and protective mechanisms. There are 2 types of Hsps, i.e., stress-inducible and constitutive types. In addition, it is well known that Hsps act as molecular chaperones to maintain the homeostasis of organisms (1). Recently, much information has become available on the specific role of individual Hsps. In particular, there are many significant reports regarding Hsp70 family member proteins that are closely involved in cell death. It has been reported that Hsp70 inhibits apoptosis by hindering the activation of JNK (2), or by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome (3). In contrast, Hsp70 promotes apoptosis. For example, overexpression of Hsp70 was found to enhance TCR and fas-mediated apoptotic cell death (4). Among the Hsp70 family, Hsp70 and the constitutively expressed 73-kDa heat shock cognate protein (Hsc)70 have been found to be located in the cytosol and to migrate to the nucleus after specific stress (5), but are also expressed on the cell surface and interact with various types of receptors (6–8). It has also been reported that Hsps such as Hsp70 and Hsc70 are expressed in the glycosphingolipid-enriched microdomain (GEM) on the cell surface (9,10).
Sialic acid-binding lectin (SBL) isolated from Rana catesbeiana oocytes was identified as a lectin, since SBL agglutinated certain types of tumor cells and the agglutination was inhibited by glycoprotein or ganglioside-containing sialic acid (11–13). Agglutination induced by SBL was observed only in tumor cells but not in normal red blood cells and fibroblasts (13). The amino acid sequence of SBL shows that it has homology to members of the RNase A superfamily, and it has been revealed that SBL has pyrimidine base-specific ribonuclease activity (14–17). The antitumor effect of SBL was reported using P388 and L1210 murine leukemia cells in vitro and sarcoma 180 cells and Ehrlich and Mep 2 ascites cells in vivo(18–20). We recently reported that SBL had a cytotoxic effect on various leukemia cells including MDR cells and showed that this cytotoxicity was induced through multiple apoptotic signaling pathways (21). Furthermore, data indicate that the SBL receptor (SBLR) may exist in the GEM on the cell surface (Tatsuta et al, unpublished data). In the present study, we investigated the involvement of Hsps in SBL-induced apoptosis, focusing on Hsp70 and Hsc70 that have been reported to exist in the GEM on the cell surface.
Materials and methods
Materials
SBL was isolated by sequential chromatography on Sephadex G-75, DEAE-cellulose, hydroxyapatite and SP-Sepharose as described previously (13). The anti-SBL antibody was established in our laboratory. The anti-caspase-3 antibody was purchased from BD Biosciences (Franklin Lakes, NJ, USA). The anti-Hsp70 and Hsc70 antibodies were purchased from Stressgen (Kampenhout, Belgium). The horseradish peroxidase (HRP)-conjugated anti-rabbit IgG antibody and the fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit antibody were purchased from Cedarlane (Hornby, Ontario, Canada). Quercetin was from Cayman Chemical Company (Ann Arbor, MI, USA).
Cell culture
Mouse leukemia P388 cells were obtained from the Cell Resource Center of Biomedical Research, Institute of Development, Aging and Cancer, Tohoku University (Sendai, Japan). Cells were routinely maintained in RPMI-1640 medium (Nissui Pharmaceutical Co. Ltd., Tokyo, Japan) supplemented with 10% fetal calf serum (FCS), penicillin (100 U/ml) and streptomycin (100 μg/ml) at 37°C in a 95% air and 5% CO2 atmosphere.
Detection of DNA fragmentation
The cells (2×105 cells/ml) were cultured in 96-well plates (100 μl/well). After treatment with SBL, the cells were collected by centrifugation, washed with PBS, then lysed with cell lysis buffer [50 mM Tris-HCl (pH 6.8), 10 mM EDTA, 0.5% (w/v) sodium N-lauroylsarcosinate]. The samples were incubated with RNase A (final concentration, 500 μg/ml) for 30 min at 50°C, before being digested with proteinase K (final concentration, 500 μg/ml) for 30 min at 50°C. After the samples were electrophoresed on 1.8% agarose gel, DNA bands were visualized by ethidium bromide (EtBr) staining.
Western blotting
Whole cell lysate was prepared with extraction buffer [10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 5 mM EDTA (pH 8.0), 1 mM phenylmethylsulfonyl fluoride (PMSF) and 1 tablet/10 ml protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN, USA)]. Lysates from the membrane, cytosol and nuclear fractions were prepared by ProteoExtract Subcellular Proteome Extraction kit (Merck Millipore, Billerica, MA, USA). Soluble proteins were collected, and concentrations were measured by the DC protein assay kit (Bio-Rad, Richmond, CA, USA) in accordance with the manufacturer’s instructions. Proteins were separated by SDS-PAGE and transferred to a polyvinylidene difluoride (PVDF) membrane (GE Healthcare, Little Chalfont, UK). The membrane was blocked using 5% fat-free skim milk for 1 h. After the membrane was washed with TBST [20 mM Tris-HCl (pH 7.6), 137 mM NaCl, 0.05% Tween-20], primary and secondary antibodies were added to the membrane, respectively. The proteins on the membrane were detected using ECL western blotting detection reagents (GE Healthcare). The intensity of the bands was calculated by Quantity One software (Bio-Rad).
Flow cytometric analysis of SBLR, Hsp70 and Hsc70
For detection of SBLR, cells were treated with SBL for 30 min at 4°C, washed with PBS, and incubated with the anti-SBL antibody for 30 min at 4°C. Cells were washed with PBS, and then FITC-labeled anti-rabbit IgG was added and incubated for 30 min at 4°C. For detection of Hsp70 and Hsc70, cells were treated with anti-Hsp70 and anti-Hsc70 antibodies for 30 min at 4°C, washed with PBS and incubated with FITC-labeled anti-rabbit IgG for 30 min at 4°C, respectively. Fluorescence intensity was determined using a FACSCalibur flow cytometer (Becton-Dickinson).
Reverse transcription and polymerase chain reaction (RT-PCR)
Total cellular RNA was isolated from the cells using TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA). Reverse transcription (RT) was performed using ReverTra Ace (Toyobo, Osaka, Japan) with total RNA (1 μg) and oligo(dT)12–18 primers. The RT reaction mixture (1 μl) was subjected to PCR for 25, 40 and 30 cycles for GAPDH, Hsp70 and Hsc70, respectively, in a final volume of 20 μl of Taq DNA polymerase (1.25 U) (ABgene, Epsom, UK) and gene-specific forward and reverse primers for each gene. After initial denaturation at 94°C for 2 min, each of the cycles consisted of 94°C for 30 sec, 50°C for 30 sec and 72°C for 30 sec. The PCR products were separated on 1.5% agarose gel, and the bands were visualized with EtBr staining. The intensity of bands was calculated by Quantity One software.
Measurement of cell viability
Cell viability was determined by the trypan blue dye exclusion assay. The cells (2×105 cells/ml) were cultured with SBL (2 μM) and/or quercetin (5 μM) in 96-well plates. After treatment with SBL and/or quercetin, the cells were stained with 0.25% trypan blue, and both viable and nonviable cells were counted.
Statistical analysis
Each experiment was performed at least in triplicate. The results are expressed as the means ± standard deviation. Statistical analysis was performed using unpaired Student’s t-tests; P<0.05 was considered to indicate a statistically significant difference.
Results
SBL-induced apoptosis in P388 cells
We recently reported that SBL induces apoptosis in various leukemia cell lines. In human leukemia Jurkat cells, typical apoptotic morphological change such as karyorrhexis, nuclear condensation and fragmentation, or apoptotic biological changes such as phosphatidylserine (PS) externalization, activation of caspases, DNA fragmentation were observed after treatment with SBL (21). In the present study, the apoptosis-inducing effect of SBL in P388 cells was analyzed by the detection of activated caspase-3. Caspase-3 activity was monitored by use of DEVD-pNA. The activity of caspase-3 was observed and maximized at 6 h of treatment (Fig. 1). As a concequence, SBL-induced apoptosis in P388 cells and the execution process may start as early as 6 h.
Expression of SBLR, Hsp70 and Hsc70 on the P388 cell membrane
It has been suggested that SBL binds to the cell membrane to exert its antiproliferative effects which indicates the existence of SBLR. We analyzed the involvement of Hsps in SBL-induced apoptosis. We analyzed the expression of SBLR, Hsp70 and Hsc70 on the cell membrane by flow cytometric analysis. The results showed that both Hsp70 and Hsc70 were expressed on the cell membrane as well as SBLR (Fig. 2).
Distribution of Hsp70 and Hsc70 in SBL-treated P388 cells
Our next experiment was designed to elucidate the localization of Hsp70 and Hsc70 after stimulation of SBL in P388 cells. After treatment with SBL, the cells were lysed and fractionated into the membrane, cytosol and nuclear fractions, and then the amounts of Hsp70 or Hsc70 were analyzed by western blotting. The results showed that Hsp70 in the membrane fraction at 6 h of treatment was decreased 34% when compared to the 0 h-control and then gradually increased (Fig. 3A). In the cytosol fraction, both Hsp70 and Hsc70 were transiently increased at 3 h of treatment, and a transient increase was also observed in the nuclear fraction at 9 h of treatment (Fig. 3B and C). After treatment with SBL, the localization of Hsp70 and Hsc70 was altered when compared to that in the cells without SBL treatment. Notably, SBL-induced activation of caspase-3 began to be observed, just after the amounts of Hsp70 and Hsc70 in the cytosol fraction reached maximum levels.
Effect of quercetin on expression of Hsp70 or Hsc70
To clarify the relationship between Hsp70 and Hsc70 in SBL-induced apoptosis, we treated P388 cells with quercetin, a known bioflavonoid which decreases the expression of Hsp70. Treatment with quercetin for 12 h resulted in a 60% reduction in Hsp70 at the mRNA level and a 50% reduction at the protein level (Fig. 4). By contrast, quercetin did not affect the expression of Hsc70 at the mRNA or protein level.
Effect of quercetin on the binding of SBL to P388 cells
As we confirmed that quercetin decreases the expression of Hsp70, sialidase treatment of cells was found to abolish tumor cell agglutination and the antiproliferative effect induced by SBL, and the existence of SBLR in the GEM on the cell surface has been suggested (13). In the present study, we investigated the possible involvement of Hsp70 and Hsc70 known Hsps which exist on the GEM, in SBL-induced apoptosis.
We found that Hsp70 and Hsc70 were expressed on the P388 cell surface as well as SBLR (Fig. 2). Distribution of Hsp70 and Hsc70 was analyzed after treatment with SBL, and expression of Hsp70 and Hsc70 in the cytosol was dramatically increased immediately prior to the execution of apoptosis in SBL-treated P388 cells (Figs. 1 and 3). Next we studied the functional relationship of Hsps and the cytotoxic activity of SBL by the use of quercetin. Quercetin was previously found to decrease the expression of Hsp70 at the mRNA level by inhibiting the activation of HSF1 (23). The expression of Hsp70 was decreased at both the mRNA and protein levels in the quercetin-treated cells (Fig. 4). We found that binding of SBL to P388 cells was not affected by a decrease in Hsp70 expression by quercetin. The result indicates that Hsp70 itself may not be the receptor for SBL (Fig. 5). However, further study revealed that a decrease in Hsp70 by quercetin inhibited both SBL-induced cytotoxicity and apoptosis (Fig. 6), suggesting the important role that Hsp70 plays in SBL-induced apoptosis.
Various reports have indicated a relationship between Hsps, particularly the Hsp70 family, and various receptors on the cell surface. It was reported that Hsp70 and Hsc70 possibly interact with CD14, CD40 and the toll-like receptor family members (24–26). Notably, Guerrero and Moreno (27) reported that Hsc70 and integrin αvβ3 formed a complex in the GEM and act as a receptor for rotavirus and may participate in the process of adsorption and penetration of the viruses into cells. In the present study, we showed that binding of SBL was not affected by a decrease in the expression of Hsp70, but an attenuated induction of apoptosis was noted. It is possible that Hsps on the P388 cell surface may interact with SBLR or participate in the penetration of SBL into cells, and may affect the cytotoxicity of SBL, as cell susceptibility to RNase can be affected by binding as well as the internalization or translocation of RNases as described above. Since the expression of Hsc70 was not affected by quercetin, studies to clarify the possible involvement of Hsc70 or other Hsps in the function of SBL will be undertaken.
In summary, the present study demonstrated that Hsp70 and Hsc70 are expressed on the P388 cell surface as well as SBLR, and their expression levels are markedly increased in the cytosol immediately prior to the execution of apoptosis following SBL treatment. A functional study of Hsp70 revealed that decreased expression of Hsp70 suppressed the apoptosis induced by SBL. It is suggested, for the first time, that Hsps participate in the antitumor effect of cytotoxic RNases.
Acknowledgements
This study was supported in part by a Grant-in-Aid from the ‘Academic Frontier’ Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
References
Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS and Van Der Vusse GJ: Heat shock proteins and cardiovascular pathophysiology. Physiol Rev. 81:1461–1497. 2001.PubMed/NCBI | |
Mosser DD, Caron AW, Bourget L, Denis-Larose C and Massie B: Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol. 17:5317–5327. 1997.PubMed/NCBI | |
Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, Tailor P, et al: Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol. 2:469–475. 2000. View Article : Google Scholar : PubMed/NCBI | |
Liossis SN, Ding XZ, Kiang JG and Tsokos GC: Overexpression of the heat shock protein 70 enhances the TCR/CD3- and Fas/Apo-1/CD95-mediated apoptotic cell death in Jurkat T cells. J Immunol. 158:5668–5675. 1997.PubMed/NCBI | |
Welch WJ: Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol Rev. 72:1063–1081. 1992.PubMed/NCBI | |
Bausero MA, Page DT, Osinaga E and Asea A: Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis. Tumour Biol. 25:243–251. 2004. View Article : Google Scholar : PubMed/NCBI | |
Calderwood SK, Mambula SS, Gray PJ Jr and Theriault JR: Extracellular heat shock proteins in cell signaling. FEBS Lett. 581:3689–3694. 2007. View Article : Google Scholar : PubMed/NCBI | |
Sugawara S, Kawano T, Omoto T, Hosono M, Tatsuta T and Nitta K: Binding of Silurus asotus lectin to Gb3 on Raji cells causes disappearance of membrane-bound form of HSP70. Biochim Biophys Acta. 1790:101–109. 2009. | |
Chen S, Bawa D, Besshoh S, Gurd JW and Brown IR: Association of heat shock proteins and neuronal membrane components with lipid rafts from the rat brain. J Neurosci Res. 81:522–529. 2005. View Article : Google Scholar : PubMed/NCBI | |
Broquet AH, Thomas G, Masliah J, Trugnan G and Bachelet M: Expression of the molecular chaperone Hsp70 in detergent-resistant microdomains correlates with its membrane delivery and release. J Biol Chem. 278:21601–21606. 2003. View Article : Google Scholar : PubMed/NCBI | |
Kawauchi H, Sakakibara F and Watanabe K: Agglutinins of frog eggs: a new class of proteins causing preferential agglutination of tumor cells. Experientia. 31:364–365. 1975. View Article : Google Scholar : PubMed/NCBI | |
Sakakibara F, Kawauchi H, Takayanagi G and Ise H: Egg lectin of Rana japonica and its receptor glycoprotein of Ehrlich tumor cells. Cancer Res. 39:1347–1352. 1979. | |
Nitta K, Takayanagi G, Kawauchi H and Hakomori S: Isolation and characterization of Rana catesbeiana lectin and demonstration of the lectin-binding glycoprotein of rodent and human tumor cell membranes. Cancer Res. 47:4877–4883. 1987.PubMed/NCBI | |
Titani K, Takio K, Kuwada M, Nitta K, Sakakibara F, Kawauchi H, Takayanagi G and Hakomori S: Amino acid sequence of sialic acid binding lectin from frog (Rana catesbeiana) eggs. Biochemistry. 26:2189–2194. 1987. View Article : Google Scholar : PubMed/NCBI | |
Kamiya Y, Oyama F, Oyama R, Sakakibara F, Nitta K, Kawauchi H, Takayanagi Y and Titani K: Amino acid sequence of a lectin from Japanese frog (Rana japonica) eggs. J Biochem. 108:139–143. 1990.PubMed/NCBI | |
Nitta K, Oyama F, Oyama R, Sekiguchi K, Kawauchi H, Takayanagi Y, Hakomori S and Titani K: Ribonuclease activity of sialic acid-binding lectin from Rana catesbeiana eggs. Glycobiology. 3:37–45. 1993. View Article : Google Scholar : PubMed/NCBI | |
Okabe Y, Katayama N, Iwama M, Watanabe H, Ohgi K, Irie M, Nitta K, et al: Comparative base specificity, stability, and lectin activity of two lectins from eggs of Rana catesbeiana and R. japonica and liver ribonuclease from R. catesbeiana. J Biochem. 109:786–790. 1991.PubMed/NCBI | |
Nitta K, Ozaki K, Ishikawa M, Furusawa S, Hosono M, Kawauchi H, Sasaki K, et al: Inhibition of cell proliferation by Rana catesbeiana and Rana japonica lectins belonging to the ribonuclease superfamily. Cancer Res. 54:920–927. 1994.PubMed/NCBI | |
Nitta K, Ozaki K, Tsukamoto Y, Furusawa S, Ohkubo Y, Takimoto H, Murata R, et al: Characterization of a Rana catesbeiana lectin-resistant mutant of leukemia P388 cells. Cancer Res. 54:928–934. 1994. | |
Nitta K, Ozaki K, Tsukamoto Y, Hosono M, Ogawakonno Y, Kawauchi H, Takayanagi Y, et al: Catalytic lectin (leczyme) from bullfrog (Rana catesbeiana) eggs: Mechanism of tumoricidal activity. Int J Oncol. 9:19–23. 1996.PubMed/NCBI | |
Tatsuta T, Hosono M, Sugawara S, et al: Sialic acid-binding lectin (leczyme) induces caspase-dependent apoptosis-mediated mitochondrial perturbation in Jurkat cells. Int J Oncol. 43:1402–1412. 2013. | |
Haigis MC, Kurten EL and Raines RT: Ribonuclease inhibitor as an intracellular sentry. Nucleic Acids Res. 31:1024–1032. 2003. View Article : Google Scholar : PubMed/NCBI | |
Hosokawa N, Hirayoshi K, Kudo H, Takechi H, Aoike A, Kawai K and Nagata K: Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids. Mol Cell Biol. 12:3490–3498. 1992.PubMed/NCBI | |
Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC and Calderwood SK: HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 6:435–442. 2000. View Article : Google Scholar : PubMed/NCBI | |
Becker T, Hartl FU and Wieland F: CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J Cell Biol. 158:1277–1285. 2002. View Article : Google Scholar : PubMed/NCBI | |
Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA and Calderwood SK: Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem. 277:15028–15034. 2002. View Article : Google Scholar : PubMed/NCBI | |
Guerrero CA and Moreno LP: Rotavirus receptor proteins Hsc70 and integrin αvβ3 are located in the lipid microdomains of animal intestinal cells. Acta Virol. 56:63–70. 2012. |